Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12142606 | PMC |
| http://dx.doi.org/10.1016/j.ekir.2025.02.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The role of N6-methyladenosine (mA) RNA methylation modification in kidney diseases: from mechanism to therapeutic potential.
PeerJ
September 2025
Changzhou Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Traditional Chinese Medicine, Changzhou, China.
Background: Kidney disease is a major global health issue, causing numerous deaths and a loss of life years. This prompts us to explore potential targets or mechanisms that may increase the likelihood of diagnosing and treating kidney diseases. N6-methyladenosine (mA) modifications dynamically regulate RNA through "writer" enzymes, "eraser" enzymes, and "reader" proteins, influencing its processing, stability, and translation efficiency.
View Article and Find Full Text PDFCollagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle.
Genes (Basel)
May 2025
Department of Nephrology, Dialysis and Transplantation, AULSS8 BERICA, San Bortolo Hospital, 36100 Vicenza, Italy.
Pathogenic variants in type IV collagen genes (, , ) are classically associated with Alport syndrome (AS), a hereditary nephropathy primarily affecting the glomerular basement membrane (GBM). Recent findings, however, suggest a broader phenotypic spectrum that includes renal cyst formation, raising questions about overlapping mechanisms with other cystic kidney diseases. Clinically, renal cysts have been increasingly reported in patients with autosomal dominant and X-linked forms of Alport syndrome, particularly in association with glycine missense variants.
View Article and Find Full Text PDFDecoding Glomerular Disease: Baseline Profiles and Insights From the I-TANGIBLE Registry.
Kidney Int Rep
May 2025
George Institute for Global Health India, UNSW, New Delhi, India.
Decoding diabetic kidney disease: a comprehensive review of interconnected pathways, molecular mediators, and therapeutic insights.
Diabetol Metab Syndr
June 2025
Research Unit of Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum München, 85764, Neuherberg, Germany.
Background: Diabetic kidney disease (DKD) is a chronic kidney condition that arises from prolonged hyperglycaemia that can progress to kidney failure, severe morbidity, and mortality if left untreated. It is the major cause of chronic kidney disease among people who have diabetes, accounting for a significant percentage of patients with end-stage kidney disease who require kidney replacement therapy.
Main Body: In DKD, numerous dysbalanced metabolic, haemodynamic, inflammatory signalling pathways, and molecular mediators interconnect, creating a feedback loop that promotes general kidney damage.
The association between elevated preoperative red cell distribution width and worsening kidney function after noncardiac operation. A propensity score and competing risk weighted retrospective cohort study.
BJA Open
March 2025
Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
Background: Elevated red cell distribution width (RDW) is associated with increased postoperative mortality, but less is known about kidney outcomes. This study investigated the association between elevated preoperative RDW and postoperative worsening of long-term kidney function and incidence of acute kidney injury.
Methods: This retrospective cohort study included patients ≥18 yr undergoing noncardiac operation at Landspitali-The National University Hospital of Iceland between 2005 and 2018.